Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.19.8075

Prognostic Value of C-Reactive Protein in Esophageal Cancer: a Meta-analysis  

Zheng, Tian-Liang (Department of Thoracic Surgery, the First Affiliated Hospital of Zhengzhou University)
Cao, Ke (Department of Laboratory Medicine, Zhengzhou Hospital of Traditional Chinese Medicine)
Liang, Cui (Department of Cardiology, the First Affiliated Hospital of Zhengzhou University)
Zhang, Kai (Department of Respiratory Medicine, the First Affiliated Hospital of Zhengzhou University)
Guo, Hai-Zhou (Department of Thoracic Surgery, the First Affiliated Hospital of Zhengzhou University)
Li, De-Ping (Department of Acupuncture, Zhengzhou Hospital of Traditional Chinese Medicine)
Zhao, Song (Department of Thoracic Surgery, the First Affiliated Hospital of Zhengzhou University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.19, 2014 , pp. 8075-8081 More about this Journal
Abstract
Background: The classical inflammatory biomarker, C-reactive protein (CRP), has been identified to be related to progression of esophageal cancer. Some research showed that elevated pretreatment serum CRP indicated a poor prognosis, but results have been inconsistent. Materials and Methods: We searched the Medline, Embase and the Cochrane Central Search Library for suitable studies and a meta-analysis of eleven (1,886 patients) was conducted to examine the relationship between elevated serum CRP level and overall survival (OS) in esophageal cancer cases. Moreover, correlation analyses were conducted to assess links between pretreatment serum CRP level and tumor node metastasis (TNM) stage as well as T, N, M grade, respectively. Results: The pooled analysis showed that elevated pretreatment serum CRP level was significantly associated with poorer overall survival (HR 2.09, 95%CI 1.52-2.87, p<0.01). Subgroup analyses were conducted by "country", "cut-off value", "treatment" and "number of patients", and no single factor could alter the result. Elevated pretreatment serum CRP was significantly correlated with more advanced TNM stage and T, N, M grade respectively. Conclusions: Elevated pretreatment serum CRP levels are associated with poorer prognosis in esophageal cancer patients, and could serve as a useful biomarker for outcome prediction.
Keywords
C-reactive protein; esophageal cancer; prognosis; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Feng JF, Zhao HG, Liu JS, et al (2013). Significance of preoperative C-reactive protein as a parameter in patients with small cell carcinoma of the esophagus. Onco Targets Ther, 6, 1147-51.
2 Fujiwara H, Suchi K, Okamura S, et al (2011). Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer. J Surg Oncol, 103, 62-8.   DOI
3 Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 340, 448-54.   DOI   ScienceOn
4 Gockel I, Dirksen K, Messow CM, et al (2006). Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol, 12, 3746-50.
5 Guillem P, Triboulet JP (2005). Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus, 18, 146-50.   DOI   ScienceOn
6 Hu Q, Gou Y, Sun C, et al (2014). The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis. Urol Oncol, 32, 1-8.   DOI
7 Guo YZ, Pan L, Du CJ, et al (2013). Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev, 14, 243-8.   DOI   ScienceOn
8 Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.   DOI   ScienceOn
9 Holmes RS, Vaughan TL (2007). Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol, 17, 2-9.
10 Iimura Y, Saito K, Fujii Y, et al (2009). Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J Urol, 181, 1004-12.   DOI   ScienceOn
11 Ikeda M, Natsugoe S, Ueno S, et al (2003). Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma. Ann Surg, 238, 197-202.
12 Janeway CA, Jr., Medzhitov R (2002). Innate immune recognition. Annu Rev Immunol, 20, 197-216.   DOI   ScienceOn
13 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
14 Lyronis ID, Baritaki S, Bizakis I, et al (2005). Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers, 20, 5-10.
15 Mayne ST, Navarro SA (2002). Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr, 132, 3467-70.
16 Nakatsu T, Motoyama S, Maruyama K, et al (2012). Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes. Surg Today, 42, 652-8.   DOI
17 Meng YQ, Cao X, Wen ZS, et al (2014). Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma. Dis Esophagus, 27, 670-7.   DOI
18 Miyata H, Yamasaki M, Kurokawa Y, et al (2011). Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer. Exp Ther Med, 2, 879-85.
19 Nozoe T, Korenaga D, Futatsugi M, et al (2003). Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker. Cancer Lett, 192, 89-95.   DOI
20 Motoyama S, Mori K, Kamei T, et al (2013). Evaluation of the risk of lymph node metastasis using CRP 1846C>T genetic polymorphism in submucosal thoracic esophageal squamous cell carcinoma. Ann Surg Oncol, 20, 1978-84.   DOI
21 Nozoe T, Saeki H, Sugimachi K (2001). Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg, 182, 197-201.   DOI   ScienceOn
22 Shimada H, Nabeya Y, Okazumi S, et al (2003). Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol, 83, 248-52.   DOI   ScienceOn
23 Song ZB, Lin BC, Li B, et al (2013). Preoperative elevation of serum C-reactive protein as an indicator of poor prognosis for early-stage esophageal squamous cell carcinoma. Kaohsiung J Med Sci, 29, 662-6.   DOI
24 Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5.   DOI
25 Yu Q, Yu XF, Zhang SD, et al (2013). Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 5735-40.   DOI   ScienceOn
26 Vakkila J, Lotze MT (2004). Inflammation and necrosis promote tumour growth. Nat Rev Immunol, 4, 641-8.   DOI   ScienceOn
27 Vallbohmer D, Lenz HJ (2006). Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus, 19, 425-32.   DOI   ScienceOn
28 Zheng Z, Zhou L, Gao S, et al (2013). Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis. Int J Med Sci, 10, 653-64.   DOI
29 Wang CY, Hsieh MJ, Chiu YC, et al (2009). Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy. Radiother Oncol, 92, 270-5.   DOI
30 Zeh HJ, 3rd, Lotze MT (2005). Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother, 28, 1-9.   DOI
31 Zhou B, Liu J, Wang ZM, et al (2012). C-reactive protein, interleukin 6 and lung cancer risk: a meta-analysis. PLoS One, 7, 43075.   DOI
32 Dai J, Tang K, Xiao W, et al (2014). Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 15, 3369-75.   DOI
33 Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
34 Chen XL, Liao YQ, Liu JR (2014). Genotype CC of rs1800947 in the C-reactive protein gene may increase susceptibility to colorectal cancer: a meta-analysis. Asian Pac J Cancer Prev, 15, 2663-7.   DOI